Home › Funds › WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC › HALO
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC position in HALO
HALOZYME THERAPEUTICS INC · Health Care
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reported holding 1,616,472 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$178.5M, representing 0.58% of its reported portfolio and ranking #36 among its reported holdings. WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed HALO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's HALO position evolved
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC first disclosed a stake in HALO in Q4 2025 at 1,842,956 shares (US$124.0M). The position peaked in Q2 2026 at 2,511,050 shares, worth US$196.5M. Across 4 filings, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,616,472 shares valued at US$178.5M — a reduction of -894,578 shares quarter over quarter.. Notable position changes include a 37% increase in Q1 2026 (shares rose 21% over the following quarter), a 36% trim in Q3 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.84M | $124.03M | New |
| Q1 2026 | 2.53M | $163.25M | Add |
| Q2 2026 | 2.51M | $196.54M | Reduce |
| Q3 2026 | 1.62M | $178.46M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), LOS ANGELES CAPITAL MANAGEMENT LLC (US$174.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.58M sh · $174.27M · Q3 2026
- Stephens Investment Management Group LLC 1.41M sh · $156.00M · Q3 2026
- GW&K Investment Management, LLC 1.14M sh · $125.86M · Q3 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Boston Trust Walden Corp 1.04M sh · $114.35M · Q3 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
More on WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
FAQ
How long has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC held HALO?
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC has disclosed HALO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC's current position in HALO?
As of Q3 2026, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC holds 1.62M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $178.46M, representing 0.58% of its reported portfolio and ranking #36.
Has WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC been buying or selling HALO?
In the latest 13F filing (Q3 2026), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reduced its position in HALO. The position peaked in Q2 2026 at 2.51M shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, LOS ANGELES CAPITAL MANAGEMENT LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.